Comparison Between Whole Body DWI and FDG PET/CT in Patients with Simptomatic Multiple Myeloma
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study
- Status
- RECRUITING
- Phase
- N/A
A Study of OL-101 Injection in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)
- Status
- RECRUITING
- Phase
- PHASE1
64Cu-LLP2A for Imaging Hematologic Malignancies
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)
- Status
- RECRUITING
- Phase
- NA
Lymphodepleting Total Body Irradiation (TBI) Plus Cyclophosphamide Prior to Ciltacabtagene Autoleucel (Carvykti; Cilta-cel) for Multiple Myeloma (MM) Patients With Impaired Renal Function
- Status
- RECRUITING
- Phase
- PHASE1
Study of ODX (OsteoDex) in Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
The Burden of Multiple Myeloma on Patients and Caregivers Quality of Life: a Canadian Real-World Study
- Status
- COMPLETED
- Phase
- N/A
Allogeneic Anti-BCMA/GPRC5D Bispecific CAR-NK Cells (ACT-001) in Patients With Relapsed or Refractorymultiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma as Compared With Standard of Care Therapies
- Status
- COMPLETED
- Phase
- N/A
Olanzapine 2.5 vs 5 mg in Quadruplet Nausea/Vomiting Prophylaxis Before High-Dose Melphalan
- Status
- RECRUITING
- Phase
- PHASE3
Korean Post Marketing Surveillance for ELREXFIO (Elranatamab).
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Chimeric Antigen Receptor Modified T Cells Targeting BCMA for the Treatment of Relapsed/Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Study of Different Sequences of Cilta-cel, Talquetamab in Combination With Daratumumab and Teclistamab in Combination With Daratumumab Following Induction With Daratumumab, Bortezomib, Lenalidomide and Dexamethasone in Participants With Standard-risk Newly Diagnosed Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
External Beam Radiation Therapy in Combination With Talquetamab for the Treatment of Multiple Myeloma Patients With Extramedullary Disease
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
GR1803 Injection in Patients With Relapsed/Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
Study Comparing Therapy for Advanced Relapsed/Refractory Multiple Myeloma With and Without Dexamethasone
- Status
- RECRUITING
- Phase
- PHASE3
A Plant-Based Whole-Foods Meal Delivery Service for Patients With Multiple Myeloma Undergoing Autologous Hematopoietic Cell Transplant
- Status
- COMPLETED
- Phase
- NA
Finistere Myeloma Observatory (OMYFIN)
- Status
- COMPLETED
- Phase
- N/A